SI2327792T1 - Postopki in sestavki za detektiranje avtoimunskih motenj - Google Patents
Postopki in sestavki za detektiranje avtoimunskih motenjInfo
- Publication number
- SI2327792T1 SI2327792T1 SI200631700T SI200631700T SI2327792T1 SI 2327792 T1 SI2327792 T1 SI 2327792T1 SI 200631700 T SI200631700 T SI 200631700T SI 200631700 T SI200631700 T SI 200631700T SI 2327792 T1 SI2327792 T1 SI 2327792T1
- Authority
- SI
- Slovenia
- Prior art keywords
- compositions
- methods
- immune disorders
- detecting auto
- detecting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Biochemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70620505P | 2005-08-05 | 2005-08-05 | |
EP10188070.6A EP2327792B9 (en) | 2005-08-05 | 2006-08-02 | Methods and compositions for detecting auto-immune disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2327792T1 true SI2327792T1 (sl) | 2013-12-31 |
Family
ID=37663302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200631700T SI2327792T1 (sl) | 2005-08-05 | 2006-08-02 | Postopki in sestavki za detektiranje avtoimunskih motenj |
Country Status (12)
Country | Link |
---|---|
US (3) | US20070092890A1 (sl) |
EP (2) | EP1945800B1 (sl) |
AT (1) | ATE549416T1 (sl) |
AU (1) | AU2006278561C1 (sl) |
CA (1) | CA2614455A1 (sl) |
DK (1) | DK2327792T3 (sl) |
ES (2) | ES2432026T3 (sl) |
HK (1) | HK1158700A1 (sl) |
PL (1) | PL2327792T3 (sl) |
PT (1) | PT2327792E (sl) |
SI (1) | SI2327792T1 (sl) |
WO (1) | WO2007019219A2 (sl) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080057503A1 (en) | 2006-04-24 | 2008-03-06 | Genentech, Inc. | Methods and compositions for detecting autoimmune disorders |
BRPI0720035A2 (pt) * | 2006-12-06 | 2019-05-07 | Medimmune, Llc | métodos para tratar um paciente tendo uma doença ou distúrbio, para tratar um paciente com doença autoimune, para neutralizar um perfil de expressão do marcador pd indutível por ifn do tipo 1 ou ifnalfa em um paciente, para monitorar ou prognosticar progressão de doença autoimune de um paciente, para monitorar a progressão da doença de um paciente que recebe o tratamento com um agente terapêutico que liga-se a e modula a atividade de ifnalfa, para identificar um paciente como um candidato para um agente terapêutico que liga-se a e modula a atividade de ifnalfa, para diagnosticar um paciente como tendo um distùrbio associado com níveis aumentados de ifnalfa, para identificar um terapêutico candidato para o tratamento de distùrbios mediados por ifnalfa e para detectar atividade de ifn em uma amostra, conjunto de sondas, e, kit |
US20100261172A1 (en) * | 2007-05-03 | 2010-10-14 | Medimmune, Llc | Interferon alpha-induced pharmacodynamic markers |
JP5411129B2 (ja) * | 2007-05-03 | 2014-02-12 | メディミューン,エルエルシー | インターフェロンα誘導性薬力学的マーカー |
WO2008144761A2 (en) | 2007-05-21 | 2008-11-27 | Genentech, Inc. | Methods and compositions for identifying and treating lupus |
WO2009061818A1 (en) * | 2007-11-05 | 2009-05-14 | Medimmune, Llc | Methods of treating scleroderma |
ES2529593T3 (es) * | 2008-02-08 | 2015-02-23 | Medimmune, Llc | Marcadores de enfermedades y usos de los mismos |
KR20120101340A (ko) * | 2009-09-03 | 2012-09-13 | 메디뮨 엘엘씨 | 1형 인터페론 진단 |
EP2478356A1 (en) * | 2009-09-18 | 2012-07-25 | Rutgers, The State University | High-throughput biomarker segmentation utilizing hierarchical normalized cuts |
CN106929568A (zh) | 2009-10-07 | 2017-07-07 | 弗·哈夫曼-拉罗切有限公司 | 用于治疗、诊断和监控狼疮的方法 |
US20110091081A1 (en) * | 2009-10-16 | 2011-04-21 | General Electric Company | Method and system for analyzing the expression of biomarkers in cells in situ in their tissue of origin |
US8824769B2 (en) * | 2009-10-16 | 2014-09-02 | General Electric Company | Process and system for analyzing the expression of biomarkers in a cell |
ES2372762B1 (es) * | 2010-07-02 | 2012-11-28 | Consejo Superior De Investigaciones Científicas (Csic) | Método y kit para la detección de la activación de interferón y la respuesta inflamatoria independiente de interferón. |
WO2012024236A1 (en) * | 2010-08-14 | 2012-02-23 | Biogen Idec Ma Inc. | LTβR BLOCKADE: METHODS FOR OPTIMIZING THERAPEUTIC RESPONSIVENESS OF PATIENTS |
WO2016179268A1 (en) * | 2015-05-05 | 2016-11-10 | University Of Florida Research Foundation, Inc. | Diagnostic microarray, system and method |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4018653A (en) | 1971-10-29 | 1977-04-19 | U.S. Packaging Corporation | Instrument for the detection of Neisseria gonorrhoeae without culture |
US4016043A (en) | 1975-09-04 | 1977-04-05 | Akzona Incorporated | Enzymatic immunological method for the determination of antigens and antibodies |
US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
US4318980A (en) | 1978-04-10 | 1982-03-09 | Miles Laboratories, Inc. | Heterogenous specific binding assay employing a cycling reactant as label |
US4657760A (en) | 1979-03-20 | 1987-04-14 | Ortho Pharmaceutical Corporation | Methods and compositions using monoclonal antibody to human T cells |
US4424279A (en) | 1982-08-12 | 1984-01-03 | Quidel | Rapid plunger immunoassay method and apparatus |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4737456A (en) | 1985-05-09 | 1988-04-12 | Syntex (U.S.A.) Inc. | Reducing interference in ligand-receptor binding assays |
US5206344A (en) | 1985-06-26 | 1993-04-27 | Cetus Oncology Corporation | Interleukin-2 muteins and polymer conjugation thereof |
US5700637A (en) | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
US5744101A (en) * | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5225212A (en) | 1989-10-20 | 1993-07-06 | Liposome Technology, Inc. | Microreservoir liposome composition and method |
US5807522A (en) | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
US6214790B1 (en) * | 1998-04-10 | 2001-04-10 | Mayo Foundation For Medical Education And Research | Neo-tryptophan |
US20020081597A1 (en) | 2000-03-31 | 2002-06-27 | Genentech, Inc. | Compositions and methods for detecting and quantifying gene expression |
US20030148298A1 (en) * | 2001-04-03 | 2003-08-07 | O''toole Margot | Methods for diagnosing and treating systemic lupus erythematosus disease and compositions thereof |
US6905827B2 (en) * | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
AU2003299503A1 (en) * | 2002-05-16 | 2004-06-15 | Vanderbilt University | Method for predicting autoimmune diseases |
US7118865B2 (en) * | 2002-08-16 | 2006-10-10 | Regents Of The University Of Minnesota | Methods for diagnosing severe systemic lupus erythematosus |
US20070048301A1 (en) * | 2002-11-26 | 2007-03-01 | Bodary-Winter Sarah C | Compositions and methods for the treatment of immune related diseases |
US20040191818A1 (en) * | 2003-02-26 | 2004-09-30 | O'toole Margot Mary | Compositions and methods for diagnosing and treating autoimmune diseases |
WO2005123113A2 (en) * | 2004-06-14 | 2005-12-29 | Intermune, Inc. | Interferon compositions and methods of use thereof |
WO2006020899A2 (en) * | 2004-08-13 | 2006-02-23 | Metrigenix Corporation | Markers for autoimmune disease detection |
US7571055B2 (en) * | 2004-10-13 | 2009-08-04 | Regents Of The University Of Minnesota | Systemic lupus erythematosus |
-
2006
- 2006-08-02 PT PT101880706T patent/PT2327792E/pt unknown
- 2006-08-02 DK DK10188070.6T patent/DK2327792T3/da active
- 2006-08-02 EP EP06789292A patent/EP1945800B1/en active Active
- 2006-08-02 PL PL10188070T patent/PL2327792T3/pl unknown
- 2006-08-02 EP EP10188070.6A patent/EP2327792B9/en active Active
- 2006-08-02 CA CA002614455A patent/CA2614455A1/en not_active Abandoned
- 2006-08-02 ES ES10188070T patent/ES2432026T3/es active Active
- 2006-08-02 ES ES06789292T patent/ES2383966T3/es active Active
- 2006-08-02 WO PCT/US2006/030241 patent/WO2007019219A2/en active Application Filing
- 2006-08-02 US US11/462,018 patent/US20070092890A1/en not_active Abandoned
- 2006-08-02 AU AU2006278561A patent/AU2006278561C1/en not_active Ceased
- 2006-08-02 SI SI200631700T patent/SI2327792T1/sl unknown
- 2006-08-02 AT AT06789292T patent/ATE549416T1/de active
-
2008
- 2008-02-20 US US12/034,494 patent/US20080318800A1/en not_active Abandoned
-
2010
- 2010-03-30 US US12/749,522 patent/US20100279298A1/en not_active Abandoned
-
2011
- 2011-11-28 HK HK11112866.3A patent/HK1158700A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20100279298A1 (en) | 2010-11-04 |
WO2007019219A2 (en) | 2007-02-15 |
AU2006278561C1 (en) | 2013-05-02 |
DK2327792T3 (da) | 2014-01-13 |
EP2327792B9 (en) | 2013-12-18 |
PL2327792T3 (pl) | 2014-03-31 |
CA2614455A1 (en) | 2007-02-15 |
ES2383966T3 (es) | 2012-06-27 |
ATE549416T1 (de) | 2012-03-15 |
AU2006278561A1 (en) | 2007-02-15 |
EP2327792B1 (en) | 2013-10-02 |
US20070092890A1 (en) | 2007-04-26 |
EP1945800B1 (en) | 2012-03-14 |
WO2007019219A3 (en) | 2007-05-31 |
PT2327792E (pt) | 2013-11-21 |
EP1945800A2 (en) | 2008-07-23 |
ES2432026T3 (es) | 2013-11-29 |
HK1158700A1 (en) | 2012-07-20 |
AU2006278561B2 (en) | 2012-11-01 |
US20080318800A1 (en) | 2008-12-25 |
EP2327792A1 (en) | 2011-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2327792T3 (pl) | Sposoby i kompozycje do wykrywania zaburzeń autoimmunologicznych | |
PH12013501101B1 (en) | Immunosuppressive polypeptides and nucleic acids | |
AP2280A (en) | Compositions and methods for increasing telomeraseactivity. | |
IL175885A0 (en) | Monovalent antibody fragments useful as therapeutics | |
WO2007002204A3 (en) | Pyrosequencing methods and related compostions | |
EP1955136A4 (en) | DOCUMENT EDITOR BASED ON GESTURES | |
WO2006104912A3 (en) | C-met mutations in lung cancer | |
IL184111A0 (en) | Prostaglandin-containing compositions and methods for enhancing the stability thereof | |
TW200727920A (en) | New regimens for oral monophasic contraceptives | |
EP1770399A4 (en) | INSPECTION INSTRUMENT | |
GB0502396D0 (en) | Tapping the vacume 1 | |
IL184834A0 (en) | Compositions and methods for the manufacture thereof | |
BRPI0417992B8 (pt) | métodos para purificar fsh humano recombinante ou uma variante de fsh | |
WO2006098998A3 (en) | Methods and compositions for modulating vascular integrity | |
WO2005118859A3 (en) | Carrier tests for albinism in the cat | |
WO2006064517A3 (en) | Methods for the purification of 20(s)-camptothecin | |
IL189803A0 (en) | Device for determining the relative position between two essentially flat elements | |
PL375122A1 (pl) | Statyw szynowy | |
IL185408A0 (en) | (+)-and(-)-8-alkyl-3-(trifluoralkylsulfonyloxy)-8-azabicycl (3.2.1)oct-2-ene | |
AU306807S (en) | Hand rail bracket | |
GB0510227D0 (en) | F e-2.1 | |
TW200706179A (en) | A composition for immunosuppression | |
GB0413113D0 (en) | The sliding scale | |
AP2244A (en) | Topical methadone compositions and methods for using the same. | |
ZA200608343B (en) | Multi-media clarifier or thickener |